SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001235010-20-000017
Filing Date
2020-08-10
Accepted
2020-08-10 16:42:46
Documents
69
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mnta-20200630.htm   iXBRL 10-Q 2533552
2 EX-10.1 a2020mnta-2013incentiv.htm EX-10.1 251788
3 EX-10.2 a2020-06x29sandozxmome.htm EX-10.2 228751
4 EX-31.1 mnta2q202010-qex311.htm EX-31.1 13611
5 EX-31.2 mnta2q202010-qex312.htm EX-31.2 9941
6 EX-32.1 mnta2q202010-qex321.htm EX-32.1 10179
12 mnta-20200630_g1.jpg GRAPHIC 49627
  Complete submission text file 0001235010-20-000017.txt   9971203

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mnta-20200630.xsd EX-101.SCH 47248
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mnta-20200630_cal.xml EX-101.CAL 93714
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mnta-20200630_def.xml EX-101.DEF 192606
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mnta-20200630_lab.xml EX-101.LAB 485027
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mnta-20200630_pre.xml EX-101.PRE 315314
13 EXTRACTED XBRL INSTANCE DOCUMENT mnta-20200630_htm.xml XML 2152081
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617 491-9700
MOMENTA PHARMACEUTICALS INC (Filer) CIK: 0001235010 (see all company filings)

IRS No.: 043561634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50797 | Film No.: 201089970
SIC: 2836 Biological Products, (No Diagnostic Substances)